nodes	percent_of_prediction	percent_of_DWPC	metapath
Zuclopenthixol—Glycosuria—Entecavir—hepatitis B	0.0246	0.0247	CcSEcCtD
Zuclopenthixol—Glycosuria—Adefovir Dipivoxil—hepatitis B	0.024	0.0241	CcSEcCtD
Zuclopenthixol—Rhinorrhoea—Telbivudine—hepatitis B	0.0202	0.0203	CcSEcCtD
Zuclopenthixol—Pregnancy—Lamivudine—hepatitis B	0.0163	0.0163	CcSEcCtD
Zuclopenthixol—Breast enlargement—Lamivudine—hepatitis B	0.0143	0.0143	CcSEcCtD
Zuclopenthixol—Liver function test abnormal—Adefovir Dipivoxil—hepatitis B	0.0131	0.0131	CcSEcCtD
Zuclopenthixol—Alanine aminotransferase increased—Adefovir Dipivoxil—hepatitis B	0.0125	0.0125	CcSEcCtD
Zuclopenthixol—Migraine—Telbivudine—hepatitis B	0.0117	0.0118	CcSEcCtD
Zuclopenthixol—Neutropenia—Entecavir—hepatitis B	0.0117	0.0118	CcSEcCtD
Zuclopenthixol—Rhinorrhoea—Lamivudine—hepatitis B	0.0114	0.0114	CcSEcCtD
Zuclopenthixol—Hyperglycaemia—Entecavir—hepatitis B	0.0113	0.0113	CcSEcCtD
Zuclopenthixol—Weight decreased—Adefovir Dipivoxil—hepatitis B	0.0111	0.0111	CcSEcCtD
Zuclopenthixol—Nasopharyngitis—Telbivudine—hepatitis B	0.0106	0.0107	CcSEcCtD
Zuclopenthixol—Jaundice—Adefovir Dipivoxil—hepatitis B	0.0106	0.0107	CcSEcCtD
Zuclopenthixol—Hepatobiliary disease—Entecavir—hepatitis B	0.0106	0.0106	CcSEcCtD
Zuclopenthixol—Alanine aminotransferase increased—Telbivudine—hepatitis B	0.0105	0.0105	CcSEcCtD
Zuclopenthixol—Hepatobiliary disease—Adefovir Dipivoxil—hepatitis B	0.0103	0.0103	CcSEcCtD
Zuclopenthixol—Oedema peripheral—Entecavir—hepatitis B	0.00988	0.00991	CcSEcCtD
Zuclopenthixol—Urinary tract disorder—Adefovir Dipivoxil—hepatitis B	0.00966	0.00969	CcSEcCtD
Zuclopenthixol—Neutropenia—Telbivudine—hepatitis B	0.00962	0.00965	CcSEcCtD
Zuclopenthixol—Connective tissue disorder—Adefovir Dipivoxil—hepatitis B	0.00961	0.00964	CcSEcCtD
Zuclopenthixol—Urethral disorder—Adefovir Dipivoxil—hepatitis B	0.00959	0.00962	CcSEcCtD
Zuclopenthixol—Immune system disorder—Entecavir—hepatitis B	0.00906	0.00909	CcSEcCtD
Zuclopenthixol—Mental disorder—Entecavir—hepatitis B	0.00879	0.00881	CcSEcCtD
Zuclopenthixol—Malnutrition—Entecavir—hepatitis B	0.00873	0.00876	CcSEcCtD
Zuclopenthixol—Hepatobiliary disease—Telbivudine—hepatitis B	0.00868	0.00871	CcSEcCtD
Zuclopenthixol—Malnutrition—Adefovir Dipivoxil—hepatitis B	0.00852	0.00854	CcSEcCtD
Zuclopenthixol—Flatulence—Adefovir Dipivoxil—hepatitis B	0.00839	0.00842	CcSEcCtD
Zuclopenthixol—Urine output increased—Lamivudine—hepatitis B	0.00836	0.00838	CcSEcCtD
Zuclopenthixol—Gynaecomastia—Lamivudine—hepatitis B	0.00827	0.0083	CcSEcCtD
Zuclopenthixol—Connective tissue disorder—Telbivudine—hepatitis B	0.00809	0.00812	CcSEcCtD
Zuclopenthixol—Leukopenia—Entecavir—hepatitis B	0.00781	0.00784	CcSEcCtD
Zuclopenthixol—Polyuria—Lamivudine—hepatitis B	0.00764	0.00767	CcSEcCtD
Zuclopenthixol—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.00738	0.0074	CcSEcCtD
Zuclopenthixol—Myalgia—Adefovir Dipivoxil—hepatitis B	0.00725	0.00727	CcSEcCtD
Zuclopenthixol—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.0072	0.00722	CcSEcCtD
Zuclopenthixol—Malnutrition—Telbivudine—hepatitis B	0.00717	0.00719	CcSEcCtD
Zuclopenthixol—Anaphylactic shock—Entecavir—hepatitis B	0.00712	0.00715	CcSEcCtD
Zuclopenthixol—Thirst—Lamivudine—hepatitis B	0.00705	0.00707	CcSEcCtD
Zuclopenthixol—Nervous system disorder—Entecavir—hepatitis B	0.00699	0.00701	CcSEcCtD
Zuclopenthixol—Skin disorder—Entecavir—hepatitis B	0.00692	0.00694	CcSEcCtD
Zuclopenthixol—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.00682	0.00684	CcSEcCtD
Zuclopenthixol—Thrombocytopenia—Adefovir Dipivoxil—hepatitis B	0.00681	0.00683	CcSEcCtD
Zuclopenthixol—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.00675	0.00677	CcSEcCtD
Zuclopenthixol—Ill-defined disorder—Telbivudine—hepatitis B	0.00665	0.00667	CcSEcCtD
Zuclopenthixol—Anorexia—Adefovir Dipivoxil—hepatitis B	0.00663	0.00665	CcSEcCtD
Zuclopenthixol—Migraine—Lamivudine—hepatitis B	0.00661	0.00663	CcSEcCtD
Zuclopenthixol—Malaise—Telbivudine—hepatitis B	0.00647	0.00649	CcSEcCtD
Zuclopenthixol—Insomnia—Entecavir—hepatitis B	0.00644	0.00646	CcSEcCtD
Zuclopenthixol—Somnolence—Entecavir—hepatitis B	0.00633	0.00635	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Adefovir Dipivoxil—hepatitis B	0.00633	0.00635	CcSEcCtD
Zuclopenthixol—Dyspepsia—Entecavir—hepatitis B	0.00627	0.00629	CcSEcCtD
Zuclopenthixol—Liver function test abnormal—Lamivudine—hepatitis B	0.0062	0.00621	CcSEcCtD
Zuclopenthixol—Gastrointestinal disorder—Entecavir—hepatitis B	0.00615	0.00617	CcSEcCtD
Zuclopenthixol—Fatigue—Entecavir—hepatitis B	0.00614	0.00616	CcSEcCtD
Zuclopenthixol—Dyspepsia—Adefovir Dipivoxil—hepatitis B	0.00612	0.00614	CcSEcCtD
Zuclopenthixol—Myalgia—Telbivudine—hepatitis B	0.00611	0.00612	CcSEcCtD
Zuclopenthixol—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.00606	0.00608	CcSEcCtD
Zuclopenthixol—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.00604	0.00606	CcSEcCtD
Zuclopenthixol—Discomfort—Telbivudine—hepatitis B	0.00603	0.00605	CcSEcCtD
Zuclopenthixol—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.006	0.00602	CcSEcCtD
Zuclopenthixol—Nasopharyngitis—Lamivudine—hepatitis B	0.006	0.00602	CcSEcCtD
Zuclopenthixol—Alanine aminotransferase increased—Lamivudine—hepatitis B	0.00592	0.00594	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Entecavir—hepatitis B	0.00583	0.00584	CcSEcCtD
Zuclopenthixol—Nervous system disorder—Telbivudine—hepatitis B	0.00574	0.00576	CcSEcCtD
Zuclopenthixol—Thrombocytopenia—Telbivudine—hepatitis B	0.00573	0.00575	CcSEcCtD
Zuclopenthixol—Skin disorder—Telbivudine—hepatitis B	0.00568	0.0057	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.00568	0.0057	CcSEcCtD
Zuclopenthixol—Sweating increased—Lamivudine—hepatitis B	0.00565	0.00567	CcSEcCtD
Zuclopenthixol—Abdominal pain—Entecavir—hepatitis B	0.00563	0.00565	CcSEcCtD
Zuclopenthixol—Body temperature increased—Entecavir—hepatitis B	0.00563	0.00565	CcSEcCtD
Zuclopenthixol—Pancytopenia—Lamivudine—hepatitis B	0.00551	0.00552	CcSEcCtD
Zuclopenthixol—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.00549	0.00551	CcSEcCtD
Zuclopenthixol—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.00549	0.00551	CcSEcCtD
Zuclopenthixol—Neutropenia—Lamivudine—hepatitis B	0.00542	0.00544	CcSEcCtD
Zuclopenthixol—Dysuria—Lamivudine—hepatitis B	0.00542	0.00544	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Telbivudine—hepatitis B	0.00533	0.00535	CcSEcCtD
Zuclopenthixol—Insomnia—Telbivudine—hepatitis B	0.00529	0.00531	CcSEcCtD
Zuclopenthixol—Paraesthesia—Telbivudine—hepatitis B	0.00526	0.00527	CcSEcCtD
Zuclopenthixol—Hyperglycaemia—Lamivudine—hepatitis B	0.00523	0.00525	CcSEcCtD
Zuclopenthixol—Dyspepsia—Telbivudine—hepatitis B	0.00515	0.00517	CcSEcCtD
Zuclopenthixol—Asthenia—Entecavir—hepatitis B	0.00511	0.00513	CcSEcCtD
Zuclopenthixol—Gastrointestinal disorder—Telbivudine—hepatitis B	0.00505	0.00507	CcSEcCtD
Zuclopenthixol—Fatigue—Telbivudine—hepatitis B	0.00505	0.00506	CcSEcCtD
Zuclopenthixol—Jaundice—Lamivudine—hepatitis B	0.00504	0.00506	CcSEcCtD
Zuclopenthixol—Pain—Telbivudine—hepatitis B	0.005	0.00502	CcSEcCtD
Zuclopenthixol—Asthenia—Adefovir Dipivoxil—hepatitis B	0.00499	0.005	CcSEcCtD
Zuclopenthixol—Sweating—Lamivudine—hepatitis B	0.00496	0.00497	CcSEcCtD
Zuclopenthixol—Pruritus—Adefovir Dipivoxil—hepatitis B	0.00492	0.00493	CcSEcCtD
Zuclopenthixol—Hepatobiliary disease—Lamivudine—hepatitis B	0.00489	0.00491	CcSEcCtD
Zuclopenthixol—Diarrhoea—Entecavir—hepatitis B	0.00487	0.00489	CcSEcCtD
Zuclopenthixol—Agranulocytosis—Lamivudine—hepatitis B	0.00483	0.00484	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Telbivudine—hepatitis B	0.00482	0.00484	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Telbivudine—hepatitis B	0.00479	0.0048	CcSEcCtD
Zuclopenthixol—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.00476	0.00477	CcSEcCtD
Zuclopenthixol—Dizziness—Entecavir—hepatitis B	0.00471	0.00473	CcSEcCtD
Zuclopenthixol—Body temperature increased—Telbivudine—hepatitis B	0.00463	0.00464	CcSEcCtD
Zuclopenthixol—Abdominal pain—Telbivudine—hepatitis B	0.00463	0.00464	CcSEcCtD
Zuclopenthixol—Connective tissue disorder—Lamivudine—hepatitis B	0.00456	0.00458	CcSEcCtD
Zuclopenthixol—Vomiting—Entecavir—hepatitis B	0.00453	0.00454	CcSEcCtD
Zuclopenthixol—Rash—Entecavir—hepatitis B	0.00449	0.00451	CcSEcCtD
Zuclopenthixol—Dermatitis—Entecavir—hepatitis B	0.00449	0.0045	CcSEcCtD
Zuclopenthixol—Headache—Entecavir—hepatitis B	0.00446	0.00448	CcSEcCtD
Zuclopenthixol—Vomiting—Adefovir Dipivoxil—hepatitis B	0.00442	0.00443	CcSEcCtD
Zuclopenthixol—Rash—Adefovir Dipivoxil—hepatitis B	0.00438	0.0044	CcSEcCtD
Zuclopenthixol—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.00438	0.00439	CcSEcCtD
Zuclopenthixol—Headache—Adefovir Dipivoxil—hepatitis B	0.00435	0.00437	CcSEcCtD
Zuclopenthixol—Nausea—Entecavir—hepatitis B	0.00423	0.00424	CcSEcCtD
Zuclopenthixol—Asthenia—Telbivudine—hepatitis B	0.0042	0.00421	CcSEcCtD
Zuclopenthixol—Immune system disorder—Lamivudine—hepatitis B	0.00419	0.00421	CcSEcCtD
Zuclopenthixol—Pruritus—Telbivudine—hepatitis B	0.00414	0.00415	CcSEcCtD
Zuclopenthixol—Nausea—Adefovir Dipivoxil—hepatitis B	0.00413	0.00414	CcSEcCtD
Zuclopenthixol—Erythema—Lamivudine—hepatitis B	0.00404	0.00405	CcSEcCtD
Zuclopenthixol—Malnutrition—Lamivudine—hepatitis B	0.00404	0.00405	CcSEcCtD
Zuclopenthixol—Diarrhoea—Telbivudine—hepatitis B	0.004	0.00402	CcSEcCtD
Zuclopenthixol—Flatulence—Lamivudine—hepatitis B	0.00398	0.00399	CcSEcCtD
Zuclopenthixol—Tension—Lamivudine—hepatitis B	0.00397	0.00398	CcSEcCtD
Zuclopenthixol—Nervousness—Lamivudine—hepatitis B	0.00393	0.00394	CcSEcCtD
Zuclopenthixol—Dizziness—Telbivudine—hepatitis B	0.00387	0.00388	CcSEcCtD
Zuclopenthixol—Tremor—Lamivudine—hepatitis B	0.00379	0.0038	CcSEcCtD
Zuclopenthixol—Ill-defined disorder—Lamivudine—hepatitis B	0.00375	0.00376	CcSEcCtD
Zuclopenthixol—Vomiting—Telbivudine—hepatitis B	0.00372	0.00373	CcSEcCtD
Zuclopenthixol—Rash—Telbivudine—hepatitis B	0.00369	0.0037	CcSEcCtD
Zuclopenthixol—Dermatitis—Telbivudine—hepatitis B	0.00369	0.0037	CcSEcCtD
Zuclopenthixol—Headache—Telbivudine—hepatitis B	0.00367	0.00368	CcSEcCtD
Zuclopenthixol—Malaise—Lamivudine—hepatitis B	0.00364	0.00366	CcSEcCtD
Zuclopenthixol—Vertigo—Lamivudine—hepatitis B	0.00363	0.00364	CcSEcCtD
Zuclopenthixol—Syncope—Lamivudine—hepatitis B	0.00362	0.00364	CcSEcCtD
Zuclopenthixol—Leukopenia—Lamivudine—hepatitis B	0.00362	0.00363	CcSEcCtD
Zuclopenthixol—Loss of consciousness—Lamivudine—hepatitis B	0.00355	0.00356	CcSEcCtD
Zuclopenthixol—Convulsion—Lamivudine—hepatitis B	0.0035	0.00351	CcSEcCtD
Zuclopenthixol—Nausea—Telbivudine—hepatitis B	0.00348	0.00349	CcSEcCtD
Zuclopenthixol—Myalgia—Lamivudine—hepatitis B	0.00344	0.00345	CcSEcCtD
Zuclopenthixol—Anxiety—Lamivudine—hepatitis B	0.00343	0.00344	CcSEcCtD
Zuclopenthixol—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.00342	0.00343	CcSEcCtD
Zuclopenthixol—Discomfort—Lamivudine—hepatitis B	0.0034	0.00341	CcSEcCtD
Zuclopenthixol—Dry mouth—Lamivudine—hepatitis B	0.00336	0.00338	CcSEcCtD
Zuclopenthixol—Anaphylactic shock—Lamivudine—hepatitis B	0.0033	0.00331	CcSEcCtD
Zuclopenthixol—Shock—Lamivudine—hepatitis B	0.00324	0.00325	CcSEcCtD
Zuclopenthixol—Nervous system disorder—Lamivudine—hepatitis B	0.00323	0.00324	CcSEcCtD
Zuclopenthixol—Thrombocytopenia—Lamivudine—hepatitis B	0.00323	0.00324	CcSEcCtD
Zuclopenthixol—Skin disorder—Lamivudine—hepatitis B	0.0032	0.00321	CcSEcCtD
Zuclopenthixol—Hyperhidrosis—Lamivudine—hepatitis B	0.00319	0.0032	CcSEcCtD
Zuclopenthixol—Anorexia—Lamivudine—hepatitis B	0.00314	0.00315	CcSEcCtD
Zuclopenthixol—Hypotension—Lamivudine—hepatitis B	0.00308	0.00309	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Lamivudine—hepatitis B	0.003	0.00301	CcSEcCtD
Zuclopenthixol—Insomnia—Lamivudine—hepatitis B	0.00298	0.00299	CcSEcCtD
Zuclopenthixol—Paraesthesia—Lamivudine—hepatitis B	0.00296	0.00297	CcSEcCtD
Zuclopenthixol—Dyspnoea—Lamivudine—hepatitis B	0.00294	0.00295	CcSEcCtD
Zuclopenthixol—Somnolence—Lamivudine—hepatitis B	0.00293	0.00294	CcSEcCtD
Zuclopenthixol—Dyspepsia—Lamivudine—hepatitis B	0.0029	0.00291	CcSEcCtD
Zuclopenthixol—Decreased appetite—Lamivudine—hepatitis B	0.00287	0.00288	CcSEcCtD
Zuclopenthixol—Gastrointestinal disorder—Lamivudine—hepatitis B	0.00285	0.00286	CcSEcCtD
Zuclopenthixol—Fatigue—Lamivudine—hepatitis B	0.00284	0.00285	CcSEcCtD
Zuclopenthixol—Pain—Lamivudine—hepatitis B	0.00282	0.00283	CcSEcCtD
Zuclopenthixol—Constipation—Lamivudine—hepatitis B	0.00282	0.00283	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Lamivudine—hepatitis B	0.00272	0.00273	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Lamivudine—hepatitis B	0.0027	0.00271	CcSEcCtD
Zuclopenthixol—Body temperature increased—Lamivudine—hepatitis B	0.00261	0.00262	CcSEcCtD
Zuclopenthixol—Abdominal pain—Lamivudine—hepatitis B	0.00261	0.00262	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Lamivudine—hepatitis B	0.00243	0.00244	CcSEcCtD
Zuclopenthixol—Asthenia—Lamivudine—hepatitis B	0.00237	0.00237	CcSEcCtD
Zuclopenthixol—Pruritus—Lamivudine—hepatitis B	0.00233	0.00234	CcSEcCtD
Zuclopenthixol—Diarrhoea—Lamivudine—hepatitis B	0.00226	0.00226	CcSEcCtD
Zuclopenthixol—Dizziness—Lamivudine—hepatitis B	0.00218	0.00219	CcSEcCtD
Zuclopenthixol—Vomiting—Lamivudine—hepatitis B	0.0021	0.0021	CcSEcCtD
Zuclopenthixol—Rash—Lamivudine—hepatitis B	0.00208	0.00209	CcSEcCtD
Zuclopenthixol—Dermatitis—Lamivudine—hepatitis B	0.00208	0.00208	CcSEcCtD
Zuclopenthixol—Headache—Lamivudine—hepatitis B	0.00207	0.00207	CcSEcCtD
Zuclopenthixol—Nausea—Lamivudine—hepatitis B	0.00196	0.00197	CcSEcCtD
Zuclopenthixol—Clozapine—CYP2A6—hepatitis B	0.000894	0.294	CrCbGaD
Zuclopenthixol—Thioproperazine—ALB—hepatitis B	0.000615	0.202	CrCbGaD
Zuclopenthixol—Thiothixene—ALB—hepatitis B	0.000605	0.199	CrCbGaD
Zuclopenthixol—Pipotiazine—ALB—hepatitis B	0.000605	0.199	CrCbGaD
Zuclopenthixol—Chlorpromazine—ALB—hepatitis B	0.000328	0.108	CrCbGaD
